BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Clinical Outcome
23 results:

  • 1. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
    Exarchou K; Kamieniarz L; Tsoli M; Victor A; Oleinikov K; Khan MS; Srirajaskanthan R; Mandair D; Grozinsky-Glasberg S; Kaltsas G; Howes N; Pritchard DM; Toumpanakis C
    Endocrine; 2021 Nov; 74(2):421-429. PubMed ID: 34120313
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Stereotactic radiofrequency ablation (SRFA) for recurrent colorectal liver metastases after hepatic resection.
    Schullian P; Johnston EW; Putzer D; Laimer G; Waroschitz G; Braunwarth E; Amann A; Maglione M; Bale R
    Eur J Surg Oncol; 2021 Apr; 47(4):866-873. PubMed ID: 33032865
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Stereotactic radiofrequency ablation as first-line treatment of recurrent HCC following hepatic resection.
    Schullian P; Laimer G; Putzer D; Levy E; Braunwarth E; Stättner S; Bale R
    Eur J Surg Oncol; 2020 Aug; 46(8):1503-1509. PubMed ID: 32222261
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study.
    Schullian P; Putzer D; Laimer G; Levy E; Bale R
    Eur Radiol; 2020 Feb; 30(2):950-960. PubMed ID: 31489472
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Relationship between morphological characteristics and prognosis of non-nasopharyneal EBV-associated carcinoma].
    Yin WJ; Wu YX; Liu LY; Gong L; Lan XB; Sun WY; Su D; Ni XH
    Zhonghua Bing Li Xue Za Zhi; 2019 Mar; 48(3):209-214. PubMed ID: 30831647
    [No Abstract]    [Full Text] [Related]  

  • 6. The outcome of Radiofrequency Ablation of Metastatic liver Tumors.
    Thamtorawat S; Rojwatcharapibarn S; Tongdee T; Siriapisith T
    J Med Assoc Thai; 2016 Apr; 99(4):424-32. PubMed ID: 27396228
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Enhanced liver fibrosis score predicts transplant-free survival in primary sclerosing cholangitis.
    Vesterhus M; Hov JR; Holm A; Schrumpf E; Nygård S; Godang K; Andersen IM; Naess S; Thorburn D; Saffioti F; Vatn M; Gilja OH; Lund-Johansen F; Syversveen T; Brabrand K; Parés A; Ponsioen CY; Pinzani M; Färkkilä M; Moum B; Ueland T; Røsjø H; Rosenberg W; Boberg KM; Karlsen TH
    Hepatology; 2015 Jul; 62(1):188-97. PubMed ID: 25833813
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Surveillance for hepatocellular carcinoma in a mixed-aetiology UK cohort with cirrhosis: does α-fetoprotein still have a role?
    Webb GJ; Wright KV; Harrod EC; Gorard DA; Collier JD; Evans AK
    Clin Med (Lond); 2015 Apr; 15(2):139-44. PubMed ID: 25824065
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Metalloproteinase-dependent and -independent processes contribute to inhibition of breast cancer cell migration, angiogenesis and liver metastasis by a disintegrin and metalloproteinase with thrombospondin motifs-15.
    Kelwick R; Wagstaff L; Decock J; Roghi C; Cooley LS; Robinson SD; Arnold H; Gavrilović J; Jaworski DM; Yamamoto K; Nagase H; Seubert B; Krüger A; Edwards DR
    Int J Cancer; 2015 Feb; 136(4):E14-26. PubMed ID: 25099234
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. [Surgical treatment of metastases and its impact on prognosis in patients with metastatic colorectal carcinoma].
    Sevčíková K; Ušáková V; Bartošová Z; Sabol M; Ondrušová M; Ondruš D; Spánik S
    Klin Onkol; 2014; 27(1):38-44. PubMed ID: 24635436
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Establishment of a multidisciplinary hepatocellular carcinoma clinic is associated with improved clinical outcome.
    Yopp AC; Mansour JC; Beg MS; Arenas J; Trimmer C; Reddick M; Pedrosa I; Khatri G; Yakoo T; Meyer JJ; Shaw J; Marrero JA; Singal AG
    Ann Surg Oncol; 2014 Apr; 21(4):1287-95. PubMed ID: 24318095
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma: long-term results and prognostic factors in 168 patients with cirrhosis.
    Lee DH; Lee JM; Lee JY; Kim SH; Han JK; Choi BI
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):705-15. PubMed ID: 23912493
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [The clinical outcome of mFOLFOX6 treatment for colorectal cancer patients who underwent resection of liver metastasis -comparison between synchronous and metachronous liver metastasis].
    Honjou H; Ishibashi K; Okada N; Tajima Y; Ishiguro T; Kuwabara K; Ohsawa T; Kumamoto K; Tsuji Y; Haga N; Iwama T; Ishida H
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2216-9. PubMed ID: 22202335
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Validation of biological and clinical outcome between with and without thoracotomy in liver resection: a matched cohort study.
    Yamazaki S; Takayama T; Moriguchi M; Okada S; Hayashi Y; Nakayama H; Higaki T; Sugitani M
    World J Surg; 2012 Jan; 36(1):144-50. PubMed ID: 22033623
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma.
    Schnapauff D; Denecke T; Grieser C; Collettini F; Seehofer D; Sinn M; Banzer J; Lopez-Hänninen E; Hamm B; Wust P; Gebauer B
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):581-7. PubMed ID: 21833806
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study.
    Bargellini I; Sacco R; Bozzi E; Bertini M; Ginanni B; Romano A; Cicorelli A; Tumino E; Federici G; Cioni R; Metrangolo S; Bertoni M; Bresci G; Parisi G; Altomare E; Capria A; Bartolozzi C
    Eur J Radiol; 2012 Jun; 81(6):1173-8. PubMed ID: 21466931
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Laparoscopic-assisted limited liver resection: technique, indications and results.
    Itano O; Chiba N; Maeda S; Matsui H; Oshima G; Wada T; Nakayama T; Ishikawa H; Koyama Y; Kitagawa Y
    J Hepatobiliary Pancreat Surg; 2009; 16(6):711-9. PubMed ID: 19588067
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Initial experience with a new laparoscopic ultrasound probe for guided biopsy in the staging of upper gastrointestinal cancer.
    Hassan H; Vilmann P; Sharma V; Holm J
    Surg Endosc; 2009 Jul; 23(7):1552-8. PubMed ID: 19263158
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Laparoscopic US-guided radiofrequency ablation of unresectable hepatocellular carcinoma in liver cirrhosis: feasibility and clinical outcome.
    Casaccia M; Andorno E; Nardi I; Troilo B; Barabino G; Santori G; Valente U
    J Laparoendosc Adv Surg Tech A; 2008 Dec; 18(6):797-801. PubMed ID: 18922065
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. clinical outcome after pulmonary metastasectomy from primary hepatocellular carcinoma: analysis of prognostic factors.
    Kwon JB; Park K; Kim YD; Seo JH; Moon SW; Cho DG; Kim YW; Kim DG; Yoon SK; Lim HW
    World J Gastroenterol; 2008 Oct; 14(37):5717-22. PubMed ID: 18837090
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.